Markets Businessinsider
Published September 16, 2026 · Updated September 17, 2026
Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted ...
Read the full story at Markets Businessinsider
Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder. PRESS RELEASE.
Surfaced by 4 Google Alerts
- Psychedelic press release
- Psychedelic crime
- Psychedelic biotech
- MDMA
